|
1
|
Wang JH and Jiang XQ: The epidemiological
studies of primary gallbladder carcinoma. Chin Arch Gen Surg
(Electronic Edition). 4:271–273. 2010.
|
|
2
|
Kunert-Keil C, Steinmüller F, Jeschke U,
Gredes T and Gedrange T: Immunolocation of glycodelin in human
adenocarcinoma of the lung, sqamous cell carcinoma of the lung and
lung metastases of colonic adenocarcinoma. Acta Histochem.
113:798–802. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sánchez-Tilló E, de Barrios O, Siles L,
Cuatrecasas M, Castells A and Postigo A: β-catenin/TCF4 complex
induces the epithelial-to-mesenchymal transition(EMT)-activator
ZEBl to regulate tumor invasiveness. Proc Natl Acad Sci USA.
108:19204–19209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin H, Liu HC, Zhou SB and Yu DH:
Expression of claudin-1 in gallbladder carcinoma and its
significance. J Bengbu Med Coll. 22–24. 2012.
|
|
5
|
Xiong L, Wen Y, Miao X and Yang Z:
Expressions of cell junction regulatory proteins and their
association with clinicopathologic parameters in benign and
malignant gallbladder lesions. Am J Med Sci. 342:388–394. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Svec D, Tichopad A, Novosadova V, Pfaffl
MW and Kubista M: How good is a PCR efficiency estimate:
Recommendations for precise and robust qPCR efficiency assessments.
Biomol Detect Quantif. 3:9–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hewitt KJ, Agarwal R and Morin PJ: The
claudin gene family: Expression in normal and neoplastic tissues.
BMC Cancer. 6:1862006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kominsky SL: Claudins: Emerging targets
for cancer therapy. Expert Rev Mol Med. 8:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gruber R, Börnchen C, Rose K, Daubmann A,
Volksdorf T, Wladykowski E, Vidal-Y-Sy S, Peters EM, Danso M,
Bouwstra JA, et al: Diverse regulation of claudin-1 and claudin-4
in atopic dermatitis. Am J Pathol. 185:2777–2789. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hahn-Strömberg V, Askari S, Befekadu R,
Matthiessen P, Karlsson S and Nilsson TK: Polymorphisms in the
CLDN1 and CLDN7 genes are related to differentiation and tumor
stage in colon carcinoma. APMIS. 122:636–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morgan C, Jenkins SA, Kynaston HG and Doak
SH: The role of adhesion molecules as biomarkers for the aggressive
prostate cancer phenotype. PLoS One. 8:e816662013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suren D, Yildirim M, Kaya V, Elal R,
Selcuk OT, Osma U, Yildiz M, Gunduz S and Sezer C: Expression
patterns of claudins 1, 4, and 7 and their prognostic significance
in nasopharyngeal carcinoma. J BUON. 20:212–217. 2015.PubMed/NCBI
|
|
13
|
Sappayatosok K and Phattarataratip E:
Overexpression of claudin-1 is associated with advanced clinical
stage and invasive pathologic characteristics of oral squamous cell
carcinoma. Head Neck Pathol. 9:173–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holczbauer Á, Gyöngyösi B, Lotz G, Törzsök
P, Kaposi-Novák P, Szijártó A, Tátrai P, Kupcsulik P, Schaff Z and
Kiss A: Increased expression of claudin-1 and claudin-7 in liver
cirrhosis and hepatocellular carcinoma. Pathol Oncol Res.
20:493–502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bouchagier KA, Assimakopoulos SF, Karavias
DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D,
Scopa CD and Tsamandas AC: Expression of claudins-1, −4, −5, −7 and
occludin in hepatocellular carcinoma and their relation with
classic clinicopathological features and patients' survival. In
Vivo. 28:315–326. 2014.PubMed/NCBI
|
|
16
|
Matsuoka T, Mitomi H, Fukui N, Kanazawa H,
Saito T, Hayashi T and Yao T: Cluster analysis of claudin-l and 4,
E-eadhefin, and β-catenin expression in colorectal cancers. J Surg
Oncol. 103:674–686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Süren D, Yıldırım M, Kaya V, Alikanoğlu
AS, Bülbüller N, Ylldlz M and Sezer C: Loss of tight junction
proteins (Claudin 1, 4, and 7) correlates with aggressive behavior
in colorectal carcinoma. Med Sci Monit. 20:1255–1262. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo XJ, Wang M, Jiang JX, Shi CJ, Hu J and
Huang HJ: Expression of zonula occludens-1 and Claudin-1 and it's
significance in cholangiocarcinoma. Chin J Exp Surg. 31:1739–1741.
2014.(In Chinese).
|
|
19
|
Shiozaki A, Shimizu H, Ichikawa D, Konishi
H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Iitaka D, Nakashima
S, et al: Claudin 1 mediates tumor necrosis factor alpha-induced
cell migration in human gastric cancer cells. World J
Gastroenterol. 20:17863–17876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shiozaki A, Bai XH, Shen-Tu G, Moodley S,
Takeshita H, Fung SY, Wang Y, Keshavjee S and Liu M: Claudin 1
mediates TNF-α-induced gene expression and cell migration in human
lung carcinoma cells. PLoS One. 7:e380492012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pope JL, Ahmad R, Bhat AA, Washington MK,
Singh AB and Dhawan P: Claudin-1 overexpression in intestinal
epithelial cells enhances susceptibility to adenamatous polyposis
coli-mediated colon tumorigenesis. Mol Cancer. 13:1672014.
View Article : Google Scholar : PubMed/NCBI
|
